COMPASS Pathways plc (CMPS) Stock Analysis — Probabli.AI
AI-powered analysis for CMPS (COMPASS Pathways plc): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $12.36 · Market cap: $1.6B · AI consensus: Bullish
COMPASS Pathways plc shows promising potential in the healthcare innovation sector specializing in psychedelic therapies. With strong analyst support, recent positive developments in clinical trials, and broad societal acceptance towards mental health solutions, the company is positioned for significant growth. Despite risks associated with regulatory scrutiny and the competitive landscape, the…
Probabilistic 1-Year Outlook
- Bull 6500% · Neutral 2500% · Bear 1000%
- A strong analyst consensus and positive recent developments suggest significant upside potential. However, risks associated with the clinical trial scrutiny remain.
5-Year Outlook
- Bull 7000% · Neutral 2000% · Bear 1000%
SWOT Highlights
- Strength: Innovative approach in the mental health space with psilocybin therapies.
- Strength: Strong analyst consensus supports investor confidence.
- Risk: Unprofitable with negative EPS, which might deter conservative investors.
- Risk: Clinical trial scrutiny as reported recently casts uncertainty.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
15 Wall Street analysts rate CMPS a STRONG BUY with a mean price target of $22.14.
Analysis generated May 29, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/CMPS.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.